Truffle Capital said this week that the initial closing of its new venture fund, Truffle BioMedTech, brought in $102 million (€85 million) of a hoped-for $240 million. Led by European and Asian institutional and corporate investors and family offices, the fund will look to sniff out “major breakthroughs” at North American and European research centers and […]